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The ROP2 protein and its paralogs are important
virulence factors secreted into the host cell by the
parasite Toxoplasma gondii. Here we describe the
crystal structure of a large and soluble domain of
mature ROP2, representative of the ROP2-like
protein family. This is a structure of a protein-kinase
fold that is devoid of catalytic residues and does not
bind ATP. Various structural extensions constitute
a signature of this protein family and act to maintain
the protein kinase in an open conformation. Our
ROP2 structure rules out a previous structural model
of attachment of ROP2-like proteins to the parasito-
phorous vacuole membrane. We propose an alterna-
tive mode of membrane attachment implicating
basic and amphiphatic helices present in the flexible
N terminus of ROP2.
INTRODUCTION
Toxoplasma gondii is an obligate intracellular parasite belonging
to the protozoan phylum Apicomplexa, which includes a large
number of human and animal parasites responsible for diseases
such as malaria, toxoplasmosis, coccidiosis, and cryptosporidi-
osis. As for all other members of the phylum, host cell invasion by
T. gondii involves specialized apical organelles of the invasive
stage, namely micronemes and rhoptries (Carruthers and Sibley,
1997; Dubremetz et al., 1993). The exocytosis of micronemal
proteins is associated with gliding and attachment to the host
cell (Carruthers et al., 1999; Fourmaux et al., 1996). Then,
a complex of microneme and rhoptry neck proteins contributes
to the moving junction, a transient close apposition between
the parasite and the host cell plasma membranes that propels
the parasite within the developing parasitophorous vacuole
(PV) (Alexander et al., 2005; Lebrun et al., 2005). The parasito-
phorous vacuole membrane (PVM), derived from the host
plasma membrane and rhoptry components during invasion
(Saffer et al., 1992), envelops the parasite. It constitutes an
essential interface between the parasite and the host cellStructure 17, 13compartments. Finally, proteins of the bulb of the rhoptries
(ROP proteins) are secreted by the parasite into the host cell.
Among these proteins, several belong to the so-called ROP2-
like family (hereafter Rop2s) (Beckers et al., 1994). Some
Rop2s are targeted into the cell nucleus (e.g., ROP16), whereas
most others associate with the PVM (Boothroyd and Dubremetz,
2008). In these two cellular locations, Rop2s can take part in the
hijacking of the host cell by the parasite.
Indeed, several Rop2s have been shown to be important for
parasite development. Targeted depletion of ROP2 results in
decreased host cell invasion and loss of virulence in mice (Na-
kaar et al., 2003). Genetic analyses showed an essential role of
ROP16 and 18 in parasite virulence (Saeij et al., 2006, 2007; Tay-
lor et al., 2006). In vivo, overexpression of ROP18 in tachyzoites
increases intracellular parasite multiplication (El Hajj et al., 2007).
However, their mechanism of action is still unknown.
The ROP2-like family contains at least 12 members sharing
a common C-terminal region distantly related to protein kinases
(PKs) (El Hajj et al., 2006). Rop2s also possess a peptide signal,
a prosequence cleaved off during rhoptry genesis to leave an
N-terminal tail (100–150 residues in length) upstream of their
PK fold (El Hajj et al., 2006). The full set of catalytic residues
necessary for ATP-dependent phosphorylation is conserved in
some Rop2s (such as ROP11, 16, 17, and 18) but not in others
(ROP2, 4, 5, 7, and 8). This raised the question of the role of
each Rop2 and their mode of action remained to be clarified.
In addition, the observed sequence similarities shared with clas-
sical PKs is inconsistent with the presence of a predicted trans-
membrane segment (Beckers et al., 1994; Sinai and Joiner,
2001). This suggests that the specific targeting of most Rop2s
to the PVM involves a distinct mechanism. The latter hypothesis
is reinforced by the distinct targeting of ROP16 to the nucleus
despite its strong sequence similarities with other Rop2s within
their common PK region. However, the involvement of the
N-terminal extension of Rop2s or of an unknown partner has
not been investigated thus far.
We now report crystal structures of ROP2 from the human
pathogen T. gondii. Its overall fold closely resembles that of func-
tional PKs. Despite the absence of most catalytic residues, it
may still bind peptides and thus might be involved in protein-
protein interactions. In addition, a biophysical characterization
of a short segment of the complementary N-terminal region in9–146, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 139
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Crystal Structure of ROP2the mature ROP2 suggests that it comprises an original
membrane-anchoring motif. This interaction is further confirmed
by an in vivo functional analysis of the homologous N-terminal
region in ROP18. Together, these results lead us to propose
a new role for Rop2s, a potential mechanism of regulation, and
a novel mode of membrane attachment.
RESULTS
Overall Structure and Topology
The 1.98 A˚ resolution structure of the soluble and C-terminal part
of ROP2 (residues 196–561) was determined by single-
wavelength anomalous diffraction (SAD) phasing (Table 1). The
two monomers of the asymmetric unit are almost identical
(root-mean-square deviation [rmsd] 0.13 A˚ over 350 residues).
The monomer-monomer interface is limited (578 A˚2) and is likely
Table 1. Data Collection, Phasing, and Refinement Statistics
for ROP2
Native SeMet
Data Collection
Space group C2 C2
Cell dimensions
a, b, c (A˚) 187.6, 51.3, 125.6 186.1, 51.1, 125.6
b () 128.6 128.4
Number of molecules (AU) 2 2
Wavelength (A˚) 0.9763 0.9333
Resolution (A˚)a 1.97 (2.07-1.97) 2.19 (2.28-2.19)
Rmerge (%)
a,b 6.0 (46.7) 8.5 (36.0)
I/sIa 9.0 (1.5) 8.2 (2.0)
Completeness (%)a 82.7 (65.9) 92.7 (63.5)
Redundancya 2.5 (2.5) 5.2 (4.1)
B Wilson 30.9 27.8
Refinement
Resolution (A˚) 1.98
Number of reflections 51,992
Rwork/Rfree (%)
c,d 19.3/24.1
Number of atoms
Protein 5,933
Sulfate 4
Water 524
B factors (A˚2)
Protein 32.2
Sulfate 42.4
Water 32.4
Rms deviationse
Bond lengths (A˚) 0.009
Bond angles () 1.342
a Values in parentheses refer to the outermost resolution shell.
b Rmerge = ShklSijIhkl,i  Iaverage,hklj/jShklSij Ihkl,ij 3 100.
c Rwork = ShkljFobs  Fcalcj/ShkljFobsj 3 100.
d Rfree is calculated in the same way on a subset of reflections that are not
used in the refinement (5%).
e Deviation from ideal values.140 Structure 17, 139–146, January 14, 2009 ª2009 Elsevier Ltd Alldue to crystal packing. Indeed, ROP2 is monomeric in solution
at 1 mg/ml in ammonium citrate buffer according to small-
angle X-ray scattering (SAXS) measurements (Figure 1). In
the following text, we will not distinguish between the two
monomers.
Despite various and unusual sequence extensions (Figure 2),
the overall fold of ROP2 is clearly but distantly related to the
conserved fold of PKs (Figure 3). The structure of ROP2 shows
a global sequence identity of 11% and an rmsd of 3 A˚
over 250 residues with a large panel of PKs, with no large
domain rearrangement according to FATCAT (Ye and Godzik,
2004). By comparison with other PKs, the structure of ROP2
can be divided into three parts: an original N-terminal exten-
sion and the two canonical lobes. The C-terminal lobe (residues
363–561) is the best conserved within Rop2s but also when
compared with other PKs. Its rmsd ranges from 2.2 to 2.9 A˚
(over 150–170 residues) for the closest PK structures (14% of
sequence identity). In contrast, the N-terminal lobe (residues
240–314) is more divergent, sharing only 6% sequence identity,
with rmsd’s ranging from 2.5 to 3.5 A˚ (over 90 residues). These
large sequence and structural divergences failed to provide us
with any hypothesis for the precise function of Rop2s and their
putative partner or substrate. Similarly, neither hydrophobic
nor conserved patches could be detected at the surface of
ROP2, precluding any interface prediction.
Despite a topology similar to that observed in other PKs, both
lobes show particular structural features: several additional
secondary structures are present (mainly two helices, named
herein aC0 and aH0, and three b strands on top of the N lobe:
b0, b0, and b00; underlined with black arrows in Figure 2), some
helices are longer (e.g., aD and aE, following PK nomenclature),
and one is kinked (aC; black square in Figure 2). A major
Figure 1. Crystal Structure of ROP2 and Its SAXS Envelope
A crystallographic monomer (ribbon representation, color ramped from
N terminus [blue] to C terminus [red]) is fitted into the SAXS envelope, calculated
by DAMMIN/DAMAVER using data corresponding to values of the momentum
transfer vector (q) of between 0.24 and 2.3 nm1 (the mean value of normalized
spatial discrepancy of 20 structures was 0.552, with a variation of 0.038). Left
and right are 90 views. The fit of the X-ray structure to SAXS data (using
CRYSOL) was significantly better for the monomer than for the possible crystal-
lographic P2-symmetric dimer (c values were 1.48 and 3.15 for monomer and
dimer, respectively, using data between q = 0.14 and 0.24 A˚1). This was
corroborated by Guiner analysis (using PRIMUS) and ab initio shape calcula-
tions (using DAMMIN).rights reserved
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Crystal Structure of ROP2difference with canonical PKs is the presence of a 40 residue
long extension at the N terminus that wraps around the two PK
lobes. This original extension is composed of two helical
segments (hereafter a0 and a00) that correspond, in ROP2, to resi-
dues 199–209 and 216–224, respectively. The latter folds onto
the b sheet of the N-terminal lobe, whereas the former (residues
199–209) mainly interacts with the C-terminal lobe (Figure 3).
Sequence-structure comparisons suggest that these particular
structural features constitute a specific signature of Rop2s
(Figures 2 and 3).
Three-Dimensional Cluster of Sequence Insertions
Although the various observed insertions correspond to
segments scattered throughout the primary sequence (see
Figure 2), all but one cluster on one side of the crystal structure.
They are in contact with one another through an extended
network of interactions. In ROP2, a salt bridge is formed between
Asp199 (on a0) and Arg322 (aC0) while hydrophobic contacts
Figure 2. Sequence-Structure Alignment
of Rop2s and Related PKs
Secondary structures are shown for ROP2 and the
phosphorylase kinase (PDB ID code 2PHK) and
numbered according to the nomenclature of
PKs. Sequence insertions specific to Rop2s are
underlined by black arrows. Important residues
are indicated using black symbols (star, Trp215;
square, Gln199). Positions of conserved and vari-
able residues lying in the active site of Rop2
protein kinases are indicated by filled and open
oval symbols, respectively. Hanks motifs are
labeled according to their numbering. The figure
was computed using ESPript (http://espript.ibcp.
fr/ESPript/ESPript) (Gouet et al., 1999).
connect the first helix a0 and the last helix
aH0 (a0: Val200 and Val201; aH0: Leu551
and Tyr555). The hydrophobic character
of these positions is conserved in the
subfamily of Rop2s that are targeted to
the PVM (ROP2, 4, 5, 7, 8, and 18). Various
contacts are also observed between helix
a00 and the extra b strands present at the
upper edge of the b sheet. The crystal
packing does not seem to stabilize these
extensions, because the two independent
monomers in the asymmetric unit adopt
a similar conformation that is consistent
with our SAXS data (discrepancy
factor c: 1.48; Figure 1). The large surface
of interaction between these insertions
and the protein core may stabilize the
observed protein conformation. Indeed,
a shorter construct of ROP18-(243–539)
(lacking the extra 40 residues) was rapidly
unfolding and aggregating (El Hajj et al.,
2007), whereas a longer construct,
ROP18-(172–539), which includes the
extra helices a0 and a00, was stable for days at room temperature
(data not shown).
Stabilization of an Open Conformation
The network of interactions involving the inserted structural
elements (a0, a00, aC0, and aH0) propagates to several structural
elements of the PK common core. The main areas of contact
include the three a helices that evolved the most in length (aD
and aE) or in conformation (aC) by comparison with canonical
PKs. Hydrophobic contacts (involving Ile202, Leu205, Val212,
Leu367, Leu381, and Ala385) are observed between a0 and aH0
on one side and the elongated aD and aE on the other side. Addi-
tional contacts are observed between the helices aC0 and a0 and
a b hairpin b7-b8 which, in canonical PKs, harbor the main cata-
lytic residues (Hanks motifs VIb and VII). Similarly, aC0 is in
contact with aC, which provides a residue (Hanks motif III) to
the active site. Last but not least, the loop (residues 213–217)
connecting the extra helices a0 and a00 interacts with helix aDStructure 17, 139–146, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 141
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Crystal Structure of ROP2and the hinge connecting the two main lobes of the PK fold. The
intricate network of interactions connects the whole set of extra
structural elements with the active-site cavity.
Although the N-terminal extension of the PK fold is unique in
sequence, it interacts with two regions of the PK fold that are
involved in allosteric regulation of the proteins PKA/PKB and
the MAPKKs (Pellicena and Kuriyan, 2006). Despite exhibiting
completely different sequences and conformations, the
C-terminal tail in PKB, the N-terminal extension in ROP2, and
the Fus3-binding peptides follow the same path along the
C- and N-terminal lobes (Figure 3). By analogy, we infer that
the N-terminal extension in Rop2s may interfere with interdomain
movements and the opening of the active-site cavity.
ROP2 Cannot Bind ATP
Despite the favorably opened conformation of the ROP2 crystal
structure, nucleotide entry is likely prevented by several
sequence changes. In canonical PKs, at the interface between
the two main lobes, the active-site cavity can accommodate
one ATP molecule. The overall shape of this cleft is similar in
ROP2 to that observed in the open conformation of PKs
(e.g., ATP-bound). The Hanks motifs involved in ATP recognition
and lining the cavity (motifs I–VIa) can be recognized in some
Figure 3. Comparison of ROP2 with Other Protein Kinases
Common cores of PKs are shown in green ribbons for ROP2, PKB (PDB ID
code 2UW0), and Fus3 (PDB ID code 2F49). Extensions in ROP2, PKB, and
the regulating peptide of Fus3 are shown as red ribbons. The allosteric binding
sites dubbed a ‘‘docking site’’ are indicated by a ‘‘D.’’ This figure was produced
using PyMOL (http://pymol.sourceforge.net). The star symbol indicates the
presence of a residue pointing into the ATP-binding pocket.142 Structure 17, 139–146, January 14, 2009 ª2009 Elsevier Ltd AllRop2s such as ROP11, 16, 17, and 18, but not in others
(ROP2, 4, 5, 7, and 8). In agreement, ATP fits perfectly into
molecular models of ROP11, 16, 17, and 18. A submicromolar
affinity of ROP18 for ATP is predicted using kinDOCK (Martin
et al., 2006) in line with its observed activity (El Hajj et al.,
2007). A similar affinity was predicted using a complete and
refined model (built by MODELER; see Experimental Proce-
dures) or a partial model based on a fixed backbone (SCWRL
procedure). This suggests that whereas the observed backbone
conformation of ROP2 is competent for accommodating a nucle-
otide, nucleotide binding is prevented by the side chains lining
the cavity. Indeed, residues important for ATP binding and
catalysis are mostly replaced by larger amino acids in ROP2.
Simultaneously, most of the residues lying in this cavity are highly
variable in sequence among a subset of Rop2s including ROP2,
4, 5, 7, and 8 (Figure 4). On the contrary, four other Rop2s
(ROP11, 16, 17, and 18) show a stronger conservation within
the ATP-binding cleft. The absence of evolutionary pressure to
preserve this site suggests that ROP2, 4, 5, 7, and 8 do not
bind ATP and that they are catalytically inactive protein kinases.
Among the residues pointing into the cavity of Rop2 and
preventing the binding of ATP, the tryptophan Trp215 consti-
tuted an interesting fluorescence probe despite the presence
of six other tryptophans. The latter are all buried, in agreement
with the measured emission maximum at 329 nm upon excitation
at 300 nm. Binding of nucleotide should extrude the side chain of
Trp215 from its buried position. In the buffer alone or in the
presence of MgATP or ATP, at a final concentration of 2 mM,
the fluorescence spectra of Rop2 excited at 300 nm are identical
(see Figure S1 available online). Similarly, the HSQC spectrum of
15N-labeled Rop2 was not affected by the addition of ATP
(Figure S2), whereas that of 15N-labeled Rop18 showed signifi-
cant changes (data not shown). The molecular weights of Rop2
and Rop18 prevent more precise analysis. However, the above
two experiments and our structural analysis indicate that Rop2
is unlikely to bind ATP.
Preservation of the Peptide-Binding Site
This sequence variability in the protein cavity is in sharp contrast
with the strong conservation of the buried residues stabilizing the
overall fold. Furthermore, the sequence of the C-terminal lobe of
Rop2s possesses short motifs matching Hanks motifs VII–XI
(Hanks and Hunter, 1995) that are conserved in canonical PKs
(see Figure 2). Among the latter, those involved in the building
of a peptide-binding site (motifs VIII, IX, X, and XI) are well
conserved in Rop2s. The associated structural features form
a local framework of interactions building up the peptide-binding
site, which appear highly similar in canonical PKs and in ROP2
crystal structures. Finally, the so-called activation segment, con-
necting Hanks motifs VII and VIII, is well structured in ROP2. It
adopts a conformation similar to that observed in the active
forms of other PKs. This sequence and structure conservation
of the C-terminal lobe suggests that it may still bind a peptide.
This would be reminiscent of the evolution of KIND domains
that possess a C-terminal lobe but no N-terminal lobe while still
being able to bind a protein partner for proper cellular signaling
(Ciccarelli et al., 2003). We therefore speculate that the nonenzy-
matic Rop2s act as protein-protein interaction modules. The
specific attachment of this subset of Rop2s to the PVM wouldrights reserved
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Crystal Structure of ROP2Figure 4. Sequence Conservation among
Inactive and Active Rop2s
(A) Crystal structure of ROP2. Zoom-in of the
active-site cavity with electron density of side
chains drawn. An ATP molecule was added into
the cavity by protein-protein superposition using
the ROP2 structure and PDB ID code 1PHK
following the kinDOCK procedure.
(B) A model of ROP18. Zoom-in of the active site of
a partial model of ROP18 built using SCWRL3.0
and the ROP2 crystal structure as a template.
The same ATP molecule was added as for the
ROP2 analysis. In both structures, backbone
atoms are shown in green.
(C) Pseudo-alignment. Positions lining the ATP-
binding cavity are shown as a pseudo-alignment.
$ indicates catalytic residues required for ATP
hydrolysis. Specific substitutions in ROP2 incom-
patible with ATP binding and corresponding to
variable positions among ROP2, 4, 7, and 8 are
shown in red (side chains and electronic density)
while conservative changes at positions pointing
into the cavity are shown in black. Equivalent posi-
tions in ROP18 are shown in violet (side chains
only). This figure was produced using PyMOL
(http://pymol.sourceforge.net).reinforce this functional prediction if a compatible model of
membrane insertion can be demonstrated.
Membrane Anchoring by Amphipathic Peptide
The structural role and its strong sequence conservation suggest
that helix aF is essential for the stability of canonical PKs and
Rop2s. However, the corresponding sequence stretch was previ-
ously predicted to form a transmembranesegment (Beckerset al.,
1994; Sinai and Joiner, 2001). Such a distinct role would certainly
disrupt the PK fold and the putative activity of membrane-
anchored Rop2s. Although no strong hydrophobic patch was
found on the surface of the crystal structure of ROP2, sequence
analyses of the regions upstream of the PK fold identified some
amphipathic but highly basic stretches conserved in the subset
of Rop2s that attach to the PVM.One of the arginine-richstretches
corresponds to the peptide ROP2-(105–123). It appeared largely
unfolded in water, with a strong and negative ellipticity at
199 nm. On the contrary, upon addition of SDS, a strong and posi-
tive signal appears at wavelength 194 nm whereas two negative
peaks formed at 208 and 222 nm. The composition computed by
CDNN (http://bioinformatik.biochemtech.uni-halle.de/cdnn) cor-
responded to 60% of a helix in the presence of anionic detergent.
Similarly, 2D NMR data indicated that this peptide is structured
and partially helical in the presence of deuterated lipid (Figure S3).
In addition, taking advantage of previous results on the ROP2
family protein ROP18, where we showed that ROP18 ectopically
expressed in infected cells binds to the PVM, we have studied
the effect of selected truncations in ROP18 on this binding.
The results (Figure 5) showed that the putative transmembrane
segment, but not the N terminus including the aforementioned
amphipathic stretches, is dispensable for specific attachment
to the PVM. More interestingly, the arginine-rich domains alone
appeared sufficient for targeting to the PVM (Figure 5).
Based on these data, we suggest that the N-terminal region
of PVM-targeted Rop2s mediates membrane attachment byStructure 17, 13a mechanism that involves partial membrane insertion of the
basic and helical segments.
DISCUSSION
Sequence comparisons among genomes have identified many
PKs as atypical members of this protein superfamily due to
various substitutions of catalytically important residues. The
structure of the soluble C-terminal region of ROP2 represents
to our knowledge the first structure of a nonenzymatically active
PK described to date. It indicates that the catalytically inactive
superfamily members adopt a canonical PK fold and may func-
tion as protein-protein binding modules by virtue of the
conserved peptide-binding site. This is predicted to apply to
the KIND domains detected in metazoans (Ciccarelli et al.,
2003) and to a number of atypical PKs from animal and plants
that are involved in signaling cascades despite the lack of enzy-
matic activity (Castells and Casacuberta, 2007; LaRonde-
LeBlanc and Wlodawer, 2005). The recent demonstration of an
interaction between ROP2 (or ROP4) and the dense granule
protein GRA7, after translocation to the PVM, supports our
hypothesis. Nevertheless, the site of interaction remains to be
mapped (Dunn et al., 2008).
The ROP2 structure presented here highlights a sequence
signature of this highly divergent subfamily of parasite PKs,
allowing new functional insights into the whole protein family.
The unique extensions of the Rop2 structure stabilize an open
and highly soluble conformation. In the catalytically active
Rop2s (such as ROP16 and 18), these extensions might regulate
PK activity, potentially in connection with either the secretion of
these proteins or their attachment to the PVM.
Our results also rule out an initial model of membrane
anchoring and sustain an original model of hydrophobic and
ionic interactions between the PVM and the N terminus of
ROP2. The highly positive charge of the membrane-anchoring9–146, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 143
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Crystal Structure of ROP2Figure 5. Immunofluorescence assays on BHK Cells Transfected with Truncated Versions of ROP18 and Infected with T. gondii
The V5-tagged protein was ectopically expressed in the cell cytosol. GFP was coexpressed on the transfected plasmid and served as a marker for transfection.
T. gondii-containing PVs are indicated by white arrows. A diffuse fluorescence was observed for the truncated form ROP18-(172–539). On the contrary, specific
labeling of the PVM was observed upon expression of the N terminus alone or when the previously predicted transmembrane motif was deleted (truncated forms:
ROP18-[83–192] and ROP18-[83–448], respectively).sequences may provide some specificity for the PVM, where
negatively charged lipids accumulate (Coppens, 2006).
This structure of a ROP2-like protein also creates the opportu-
nity to refine the comparative modeling of ROP18, which shows
that the latter can perfectly accommodate an ATP molecule in its
active site. Therefore, the specific features revealed in the
present structure and the vast phylogenetic distance between
this organism and its vertebrate hosts suggest a potential ratio-
nale for the design of specific inhibitors.
EXPERIMENTAL PROCEDURES
Chemicals, Bacterial Strains, and Plasmids
Isopropyl-b-D-1-thiogalactopyranoside was from ICN Biomedical. The over-
expression of ROP2 was obtained using the pQE31 vector system as
previously described (Nigro et al., 2001).
Purification
Purification was performed using an NiTA column followed by gel filtration in
200 mM salt in 50 mM Tris (pH 8). The salt nature was successively changed144 Structure 17, 139–146, January 14, 2009 ª2009 Elsevier Ltd Allfrom KPO4 to KCl and finally LiSO4 following crystallization trials and crystal
growth improvement.
Small-Angle X-Ray Scattering
Data were collected at beamline X33, at DESY, European Molecular Biology
Laboratory, Hamburg, Germany at 10C, using a wavelength of 1.5 A˚. Samples
were kept in 200 mM NH4 citrate. Data analysis and ab initio shape calculations
were performed using PRIMUS, GNOM, DAMMIN, CRYSOL, and DAMAVER
(Svergun and Koch, 2002). The SAXS envelope presented in Figure 1 is
the reference structure as computed by DAMAVER from 20 individual
DAMMIN runs.
Crystallization
Initial crystallization conditions of ROP2 were found by using a hanging-drop-
based and sparse-matrix screening strategy. Due to the presence of phos-
phate in the first protein sample, solutions containing dications were omitted
from the screens Wishart I and II (Emerald BioStructures) and the screen CSSII
(Molecular Dimensions). After stepwise refinement, well-diffracting crystals
were obtained by mixing 1 ml of the protein solution (concentration 9 mg/ml)
with an equal volume of crystallization buffer (320 mM ammonium citraterights reserved
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Crystal Structure of ROP2[pH 5.6], 2% methylpentanediol, and 15% (w/v) polyethylene glycol 2000
monomethylether), equilibrated over 0.5 ml of the same buffer.
Crystallographic Studies
X-ray diffraction data sets were collected from frozen single crystals at the
European Synchrotron Radiation Facility (Grenoble, France, beamlines ID14
and ID29) and processed with the programs MOSFLM, SCALA, and
TRUNCATE from the CCP4 program suite (CCP4, 1994) (Table 1).
The structure was solved by using a single-wavelength anomalous diffrac-
tion experiment from a highly redundant 2.2 A˚ data set of the selenomethio-
nine-labeled protein. Ten of 14 Se sites were found by direct methods with
the program SHELX-CD (Sheldrick, 2008) and refined with SOLVE (Terwilliger
and Berendzen, 1999). Initial phases were obtained by combining SAD data
with a 1.98 A˚ native data set. Phases were improved using iterative solvent flat-
tening and model building by RESOLVE, using the native data. Automatic
model building with the program Arp/wArp (Perrakis et al., 1999) based on
these refined phases led to an almost complete model. Model refinement
was performed using the program Coot (Emsley and Cowtan, 2004) and the
program REFMAC5 (Murshudov et al., 1997), using a translation/libration/
screw model (Winn et al., 2001) against the native data set at 1.98 A˚ resolution
(Table 1). In the final model, short segments of the protein were not clearly
visible in the electron density map. Most of the histidine tag, the last five resi-
dues, as well as a short stretch lying near the putative peptide-binding site
(residues 456–460) could not be modeled in the electronic density.
Tryptophan Fluorescence and NMR Spectroscopies
Tryptophan fluorescence spectra were recorded using a Sapphire2 spectro-
fluorimeter (TECAN) at a protein concentration of 0.01 mM at room tempera-
ture. Potassium phosphate, ATP, or MgATP was added to a final concentration
of 2 mM. Fluorescence was recorded between 315 and 415 nm upon excita-
tion at 300 nm. Two-dimensional 1H-15N HSQC spectra were recorded on
a Bruker Avance 600 spectrometer at 293K at a protein concentration of
0.2 mM (Rop18) and 0.4 mM (Rop2) in potassium phosphate 200 mM (pH 8)
(Rop18) or 20 mM Tris (pH 8), lithium sulfate 200 mM (Rop2).
Molecular Modeling
ROP16, 17, and 18 were manually aligned to ROP2 using ViTO (Catherinot and
Labesse, 2004). The most significant variations correspond to the buildup of an
enzymatically active PK. Partial models were obtained using SCWRL3.0 (Can-
utescu et al., 2003) and refined models were deduced using as a mixed
template both the structure of ROP2 and that of a functional PK (e.g., Protein
Data Bank [PDB] ID code 2PHK) using MODELER 7v7 (Sali and Blundell, 1993).
Circular Dichroism and NMR Spectroscopies
Peptide ROP2:105-QSPSAFRRLLRRLRFWRG-123 was purchased from Gen-
epep. UV-CD spectra were recorded using a chirascan spectrophotometer
(Applied Photophysics) at a peptide concentration of 0.02 mg/ml in either
water or 1% SDS. A two-dimensional 1H-1H NOESY spectrum was recorded
on a Bruker Avance 500 spectrometer at 293K. The peptide was dissolved
in 100 mM deuterated (d38) dodecylphosphocholine micelles in 90% H20,
10% D20 (v/v). Final peptide concentration was 2 mM and the pH was adjusted
to 5.2.
Ectopic Expression of Truncated ROP18 in BHK21-Infected Cells
A plasmid pTracer-ROP18-(83539) has been previously designed to express
in mammalian cells the mature form of the ROP18 protein spanning amino
acids 83–539 (El Hajj et al., 2007). It was used as a template for deletions of
either a short N-terminal or a short C-terminal portion of mature ROP18. These
truncations, named ROP18-(172–539) and ROP18-(83–448), were obtained by
PCR using the following primers: ML262 (50-GGATCGATTCTGAATTGGT
TTTTGAGAAG-30; Cla1 site underlined), ML263 (50-GGATCGATCATGCG
GCCGCCACTGTGCTGG-30), ML264 50-GGATCGATTGCAAGGAACGTCCA
ACTCCG-30, and ML265 50-GGATCGATGGTGATGCCTGTAGCCTGAAA-30.
Amplified and religated plasmids were sequenced. A plasmid named pTracer
ROP18-(83–192) was constructed by PCR amplification from the pROP18
plasmid (El Hajj et al., 2007) using forward primer ML193 (50-GCGGCCG
CATGGAAAGGGCTCAACACCGGGTA-30; NotI site underlined) and reverse
primer ML307 (50-GCTCTAGAATCCGCCTTCTCAAAAACCAA-30; XbaI siteStructure 17, 13underlined) and cloning into NotI and XbaI sites of pTRACER-A (Invitrogen).
BHK21 cell transient transfection with these plasmids followed by infection
with T. gondii tachyzoites and immunofluorescence studies were performed
as described previously (El Hajj et al., 2007).
SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found with this article on-
line at http://www.cell.com/structure/supplemental/S0969-2126(08)00429-2.
ACCESSION NUMBERS
The refined models and structure factors have been deposited in the Research
Collaboratory for Structural Biology (http://www.rcsb.org) under PDB ID code
2W1Z (native structure).
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